Xiu Luo

Xiu Luo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YCYongjuan Chen
Yongjuan Chen
YGYanfang Ge
Yanfang Ge
CWChunling Wu
Chunling Wu
HTHua Tang
Hua Tang
XLXiu Luo
Xiu Luo
Jiaqiang WangJiaqiang Wang
Jiaqiang Wang
ZnIn2S4, a novel two-dimensional visible light-responsive photocatalyst, has attracted much attention in the photocatalytic evolution of H2 under visible light irradiation due to its attractive intrinsic photoelectric properties and geometric configuration. However, ZnIn2S4 still has severe charge recombination, which results in moderate photocatalytic performance. Herein, we report the successful synthesis of 2D/2D ZnIn2S4/Ti3C2 nanocomposites by a facile one-step hydrothermal method. The efficiency of the nanocomposites in photocatalytic hydrogen evolution under visible light irradiation was also evaluated for different ratios of Ti3C2, and the optimal photocatalytic activity was achieved at 5% Ti3C2. Importantly, the activity was significantly higher than that of pure ZnIn2S4, ZnIn2S4/Pt, and ZnIn2S4/graphene. The enhanced photocatalytic activity is mainly due to the close interfacial contact between Ti3C2 and ZnIn2S4 nanosheets, which amplifies the transport of photogenerated electrons and enhances the separation of photogenerated carriers. This research describes a novel approach for the synthesis of 2D MXenes for photocatalytic hydrogen production and expands the utility of MXene composite materials in the fields of energy storage and conversion.

10 March 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
XLXiu Luo
Xiu Luo
ZZZhe Zhang
Zhe Zhang
CCChao Cheng
Chao Cheng
TWTao Wang
Tao Wang
DFDanzhou Fang
Danzhou Fang
XLXiao Li
Xiao Li
The so-far used Ga-68- or F-18-labelled tracers are of a relative short time window in differentiating tumor fibrosis. SPECT applicable imaging probe, 99mTc-HYNIC-FAPI-04, was synthesized and evaluated in tumor cells and animal models of FAP-positive glioma and FAP-negative hepatoma, and then compared with 18F-FDG or 68Ga-FAPI-04 PET/CT. The radio-labeling rate of 99mTc-HYNIC-FAPI-04 was greater than 90%, and the radiochemical purity was >99% after purification with sep-pak C18 column. In vitro cell uptake experiments of 99mTc-HYNIC-FAPI-04 showed good FAP binding specificity, and the cellular uptake significantly decreased when blocked by DOTA-FAPI-04, reflecting the similar targeting mechanism of HYNIC-FAPI-04 and DOTA-FAPI-04. SPECT/CT imaging showed that U87MG tumor was distinguishable and of a high uptake of 99mTc-HYNIC-FAPI-04 (2.67 ± 0.35 %ID/mL at 1.5 h post injection (h P.I.), while tumor signal of FAP-negative HUH-7 was as low as 0.34 ± 0.06 %ID/mL. At 5 h P.I., U87MG tumor was still distinguishable (1.81 ± 0.20 %ID/mL). In comparison, although U87MG tumor was of obvious 68Ga-FAPI-04 uptake and clearly visible at 1 h P.I., the tumorous radioactive signals were fuzzy at 1.5 h P.I. 99mTc-HYNIC-FAPI-04 specifically bound to FAP-positive tumors and qualified with the ability of evaluating tumor fibrosis over longer time windows.